# CPRR Laboratory Tests for Portland VA

Canonical: https://abierto.us/opportunities/36c26026f0113

- Solicitation number: 36C26026F0113
- Notice type: Award notice
- Status: Awarded to Werfen USA LLC for $316,089.70
- Department: Department of Veterans Affairs
- Contracting office: 260-Network Contract Office 20 (36C260)
- NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing
- Product or service code: 6640 Laboratory Equipment and Supplies
- Place of performance: Portland, Oregon
- County: Multnomah County (FIPS 41051). https://abierto.us/counties/multnomah-county-or-41051
- City: Portland. https://abierto.us/cities/portland-or-4159000
- First posted: December 31, 2025
- Last posted: December 31, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/f9f00d177fa34e5bb5549ec19f7e488b/view

## Description

Provide blood reagents to type and match for pre/post-transplant Veterans, and for Veterans on drug therapy for disease, at Portland VAPORHCS. Pricing tiers are based on estimated patient results per month. Equipment will not be necessary to replace. Vendor contract shall contain items and services that meet or exceed the following capabilities: Blood Bank Tube Reagents

## Award on USAspending

- Recipient: Werfen USA LLC (UEI JA87HT8KP2M2)
- Contract: 36C26026F0113 under V797D70110, delivery order
- Obligated: $63,217.94
- Competition: Full and Open Competition, 2 offers received
- Link: award number 36C26026F0113 equals the contract number; same awarding office 36C260 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_36C26026F0113_3600_V797D70110_3600/


## Publications

- December 31, 2025: Award notice. Notice f9f00d177fa34e5bb5549ec19f7e488b. https://sam.gov/workspace/contract/opp/f9f00d177fa34e5bb5549ec19f7e488b/view

## Points of contact

- Hector D Gonzalez, hector.gonzalez1@va.gov, 3605537632

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/36c26026f0113.
